James F. Benenati, MD, FSIR, has been practicing interventional radiology at the Miami Cardiac & Vascular Institute (MCVI) since 1990 and the chief medical officer for Penumbra Inc. located in Alameda, Calif.
He is the former fellowship/residency program director and was the medical director of the Non-Invasive Vascular Laboratory at MCVI and received the James F. Benenati Award for Excellence in Education in 2020 for which he was nominated by the fellows and staff at MCVI.
A clinical professor of radiology at the Florida International University Herbert Werthheim College of Medicine and collaborative professor of radiology at the University of South Florida Morsani College of Medicine, Dr. Benenati is also the founding Medical Director of the Nova Southeastern University Health Sciences BS/ RVT program.
A past-president of SIR in 2010, Dr. Benenati also chaired the 2005 SIR Annual Scientific Meeting. Over the years, he has also served on the society’s executive committee, as SIR representative to the IAC, a position he held since 2001, and has served as the president of the IAC Vascular Testing Division. Benenati delivered the Dr. Charles T. Dotter Lecture in 2014.
A clinical professor of radiology at the Florida International University Herbert Werthheim College of Medicine and collaborative professor of radiology at the University of South Florida Morsani College of Medicine, Dr. Benenati is also the founding medical director of the Nova Southeastern University Health Sciences BS/ RVT program.
A participant in numerous clinical research projects and national trials, his interests include peripheral arterial disease, abdominal aortic aneurysm therapy, management of pulmonary embolism, management of acute clot, and uterine fibroid embolization. He has also served as a program director of the International Symposium on Endovascular Therapy (ISET) for 30 years.
Dr. Benenati completed his undergraduate degree at the University of Notre Dame and attended medical school at the University of South Florida College of Medicine. He completed a diagnostic radiology residency at Indiana University School of Medicine and a fellowship in cardiovascular and interventional radiology at the Johns Hopkins University School of Medicine.
Michael C. Soulen, MD, FSIR, is currently professor of radiology at the Hospital of the University of Pennsylvania.
Dr. Soulen’s personal practice focuses on neuroendocrine tumors (NETs), the second-most prevalent GI malignancy. He is the founder of the NET Tumor Board at University of Pennsylvania and is the principal investigator of the RETNET trial, a global multi center randomized comparison of embolization techniques for NET liver metastases. He has chaired the North American Neuroendocrine Tumor Society Annual Meeting and is the first radiologist to sit on its board of directors. Dr. Soulen credits many mentors in his life, including his mother, SIR founder and 2018 Gold Medal recipient Renate L. Soulen, MD, FSIR, for their support as he started the interventional radiology clinical service at the University of Pennsylvania.
Dr. Soulen has 13 years of service on the SIR Executive Council and SIR Foundation Board of Directors, including as part of the SIR Annual Scientific Meeting Committee and on the SIR Foundation Board of Directors as Research Education Division Chair. He also served on multiple committees including SIR’s RUC, CME, council advisory, diversity benchmarking and SIR Foundation grant review committees. He presented the Dr. Charles T. Dotter Lecture in 2010. A champion for the growth of interventional oncology, Soulen was annual meeting chair and president of the WCIO, now the Society of Interventional Oncology, where he serves on the board of directors. He completed his residency at The Johns Hopkins Hospital, followed by fellowship at Thomas Jefferson University Hospital in Philadelphia.
David M. Williams, MD, FSIR, is the Kyung J. Cho Professor of Radiology and professor of internal medicine at Michigan Medicine, University of Michigan, Ann Arbor, where he has been a member of the faculty since 1983.
Dr. Williams is recognized as an international authority on endovascular treatment of aortic dissection, especially on the diagnosis and treatment of the many malperfusion syndromes that often accompany it. He is also an authority of central venous recanalization of the IVC and SVC and their major tributaries. He is author of more than 200 peer-reviewed articles, principally on these subjects.
Dr. Williams co-moderated the first SIR workshops on EVAR implantation using fluoroscopy and co-moderated SIR workshops for several years on venous recanalization. A clinical interventional radiologist for over 30 years, Dr. Williams maintains close collaborative relationships with cardiology, vascular surgery and thoracic surgery. In 2015 he received the League of Clinical Excellence Award from the University of Michigan Medical School.
Dr. Williams was born in Trenton, Mich., and graduated from Maryglade College in Memphis, Mich., with a B.A. in philosophy and obtained an M.A. in physics from Wayne State University in Detroit. After serving three years as a Navy medical physicist, he attended the University of Michigan medical school, where he completed his residency and IR specialty training. Dr. Williams notes that he owes a special debt to Kyung J. Cho, world authority on carbon dioxide vascular imaging and venous sampling and himself an SIR Gold Medal winner in 2012, helping him create his own IR philosophy and vision.